These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20189046)

  • 61. Erythropoietin, an update, and where to in the future?
    Sulková S
    EDTNA ERCA J; 1998; 24(3):30-2, 35. PubMed ID: 10392076
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypothesis: an erythropoietin honeymoon phase exists.
    Fishbane S; Miyawaki N; Szczech LA
    Kidney Int; 2010 Oct; 78(7):646-9. PubMed ID: 20631675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The challenge of reducing costs for the treatment of renal anemia with erythropoietic factors].
    Jaras JH
    Farm Hosp; 2009; 33(5):235-6. PubMed ID: 19775572
    [No Abstract]   [Full Text] [Related]  

  • 64. Chronic kidney disease: Are elevated doses of ESAs associated with adverse outcomes?
    Eckardt KU
    Nat Rev Nephrol; 2010 Oct; 6(10):566-8. PubMed ID: 20871637
    [No Abstract]   [Full Text] [Related]  

  • 65. FDA Approves First Oral Treatment for Kidney Disease-Induced Anemia.
    Harris E
    JAMA; 2023 Mar; 329(9):704. PubMed ID: 36790833
    [No Abstract]   [Full Text] [Related]  

  • 66. [Croatian consensus conference on the use of erythropoiesis-stimulating drugs in renal patients. Novi Vinodolski, 21 March 2009].
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():1-88. PubMed ID: 20387271
    [No Abstract]   [Full Text] [Related]  

  • 67. Transplantation: Does anemia correction delay kidney allograft dysfunction?
    Huang E; Bunnapradist S
    Nat Rev Nephrol; 2012 Feb; 8(4):196-8. PubMed ID: 22371244
    [No Abstract]   [Full Text] [Related]  

  • 68. After 15 years of success--perspectives of erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 2001 Sep; 16(9):1745-9. PubMed ID: 11522850
    [No Abstract]   [Full Text] [Related]  

  • 69. [The Cutting-edge of Medicine; Endocrine disorders and renal disease].
    Mukoyama M
    Nihon Naika Gakkai Zasshi; 2015 Jul; 104(7):1486-94. PubMed ID: 26513969
    [No Abstract]   [Full Text] [Related]  

  • 70. Chronic disease from a patient's point of view.
    McCLURKIN E
    Mod Hosp; 1946 Jan; 66():83. PubMed ID: 21009747
    [No Abstract]   [Full Text] [Related]  

  • 71. Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.
    Locatelli F; Minutolo R; De Nicola L; Del Vecchio L
    Drugs; 2022 Nov; 82(16):1565-1589. PubMed ID: 36350500
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Individualizing anaemia therapy.
    de Francisco AL
    NDT Plus; 2010 Dec; 3(6):519-26. PubMed ID: 25949459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter?
    De Nicola L; Locatelli F; Conte G; Minutolo R
    Drugs; 2014 Feb; 74(2):159-68. PubMed ID: 24442793
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does TREAT give the boot to ESAs in the treatment of CKD anemia?
    Singh AK
    J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034
    [No Abstract]   [Full Text] [Related]  

  • 75. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 76. Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
    Winkelmayer WC
    J Am Soc Nephrol; 2011 Jan; 22(1):1-2. PubMed ID: 21164031
    [No Abstract]   [Full Text] [Related]  

  • 77. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
    Berns JS
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TREAT versus treatment: a patient's view of a scientific interpretation.
    Prisant A
    Am J Kidney Dis; 2010 Mar; 55(3):A31-2. PubMed ID: 20189046
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.